3-(4-fluorophenyl)-1-isopropyl-N-(4-((6-(4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido)pyrimidin-4-yl)oxy)phenyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide

ID: ALA4846932

Chembl Id: CHEMBL4846932

PubChem CID: 164609146

Max Phase: Preclinical

Molecular Formula: C35H40FN9O5

Molecular Weight: 685.76

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)N4CCC(N5CCN(C)CC5)CC4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O

Standard InChI:  InChI=1S/C35H40FN9O5/c1-23(2)44-21-29(33(47)45(35(44)49)27-8-4-24(36)5-9-27)32(46)39-25-6-10-28(11-7-25)50-31-20-30(37-22-38-31)40-34(48)43-14-12-26(13-15-43)42-18-16-41(3)17-19-42/h4-11,20-23,26H,12-19H2,1-3H3,(H,39,46)(H,37,38,40,48)

Standard InChI Key:  QPIHEOATRHIZAP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4846932

    ---

Associated Targets(Human)

AXL Tchem Tyrosine-protein kinase receptor UFO (3469 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MERTK Tchem Proto-oncogene tyrosine-protein kinase MER (2687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TYRO3 Tchem Tyrosine-protein kinase receptor TYRO3 (2906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MET Tclin Hepatocyte growth factor receptor (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LCK Tclin Tyrosine-protein kinase LCK (9212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Axl Tyrosine-protein kinase receptor UFO (39 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mertk Tyrosine-protein kinase Mer (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 685.76Molecular Weight (Monoisotopic): 685.3136AlogP: 3.80#Rotatable Bonds: 8
Polar Surface Area: 146.93Molecular Species: NEUTRALHBA: 11HBD: 2
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.49CX Basic pKa: 8.14CX LogP: 3.18CX LogD: 2.26
Aromatic Rings: 4Heavy Atoms: 50QED Weighted: 0.28Np Likeness Score: -1.62

References

1. Inoue S, Yamane Y, Tsukamoto S, Azuma H, Nagao S, Murai N, Nishibata K, Fukushima S, Ichikawa K, Nakagawa T, Hata Sugi N, Ito D, Kato Y, Goto A, Kakiuchi D, Ueno T, Matsui J, Matsushima T..  (2021)  Discovery of a potent and selective Axl inhibitor in preclinical model.,  39  [PMID:33930844] [10.1016/j.bmc.2021.116137]
2. Inoue S, Yamane Y, Tsukamoto S, Murai N, Azuma H, Nagao S, Nishibata K, Fukushima S, Ichikawa K, Nakagawa T, Hata Sugi N, Ito D, Kato Y, Goto A, Kakiuchi D, Ueno T, Matsui J, Matsushima T..  (2021)  Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine derivatives as novel selective Axl inhibitors.,  48  [PMID:34271070] [10.1016/j.bmcl.2021.128247]

Source